PT-141 (bremelanotide) — an MC4R-preferential melanocortin agonist — research reference for Australia laboratory work.
PT-141 (bremelanotide) is a synthetic peptide derived from Melanotan 2 with melanocortin-receptor selectivity favoring MC4R. Published Australia literature characterizes both pharmacokinetics and behavioral assay endpoints.
Research use only. 3 Diamond Labs supplies materials strictly for in vitro and laboratory research. Nothing in this article constitutes medical, therapeutic, or dosage advice for human or animal use.
